Author:
Bor Tekdemir Zeynep,Seckin Ali Ihsan,Kacar Turgay,Yilmaz Emine,Bekiroglu Somer
Funder
Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
Arven Pharmaceuticals
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference15 articles.
1. Fukunaga R, Ishizaka-Ikeda E, Nagata S. Purification and characterization of the receptor for murine granulocyte colony-stimulating factor. J Biol Chem. 1990;265(23):14008–15.
2. Bendall LJ, Bradstock KF. G-CSF: from granulopoietic stimulant to bone marrow stem cell mobilizing agent. Cytokine Growth Factor Rev. 2014. https://doi.org/10.1016/j.cytogfr.2014.07.011 .
3. Herman AC, Boone TC, Lu HS. Characterization, formulation, and stability of Neupogen® (Filgrastim), a recombinant human GranulocyteColony stimulating factor. In: Pearlman R, Wang YJ, editors. Formulation, characterization, and stability of protein drugs. New York: Plenum Press; 1996. p. 303–28.
4. Mantovani M, Caruso C, Facchini F, Pascon R, Cagnacci P, Magalhaes V. Physicochemical and biological comparison of the first Brazilian biosimilar filgrastim with its reference product. Biosimilars. 2016. https://doi.org/10.2147/BS.S107898 .
5. Sörgel F, Lerch H, Lauber T. Physicochemical and biologic comparability of a biosimilar granulocyte Colony-stimulating factor with its reference product. BioDrugs. 2010. https://doi.org/10.2165/11585100-000000000-00000 .
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献